HSPA5 and Parkinson disease: This is further supported by studies showing that pharmacological inhibition of mitochondrial reactive oxygen species (ROS) (e.g., mitoTEMPO) or restoration of ATP via exogenous supplementation attenuates ERS markers (GRP78, CHOP) in PD models [41,44].